Brief: Oragenics Inc Announces $6.5 Mln Registered Direct Offer
24/12/2020 18:07
Dec 24 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS INC - ENTERED AGREEMENT FOR PURCHASE AND SALE
OF 14.4
MILLION SHARES OF COMMON STOCK AT $0.45/SHARE IN A REGISTERED
DIRECT OFFERING
Source text for Eikon: urn:newsml:reuters.com:*:nNDL8YcST6
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing